| HOPE FOR FIBROIDS | |||||||||||||||
|
|
Patient selection guidelines in MR-guided focused ultrasound surgery
of uterine fibroids: a pictorial guide to relevant findings in screening
pelvic MRI. Yoon SW, Lee C, Cha SH, Yu JS, Na YJ, Kim KA, Jung
SG, Kim SJ. Department of Diagnostic Radiology, College of Medicine, Pochon CHA
University Bundang CHA General Hospital, 351, Yatap-dong, Bundang-gu,
Sungnam-si, Gyunggi-do, Republic of Korea, 463-712,
jansons@cha.ac.kr.
"Uterine leiomyomas (fibroids), the most common benign tumor in women of childbearing age, can cause symptoms including dysmenorrhea, menorrhagia, urinary symptoms, pain and infertility. Hysterectomy is a common approach to treating uterine fibroids, and less invasive surgical approaches such as myomectomy and uterine artery embolization also have been shown to alleviate symptoms. Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is the only totally non-invasive surgical approved method for treating uterine fibroids. In clinical trials, MRgFUS resulted in significant relief of uterine fibroid symptoms. The safe and effective use of MRgFUS is affected by fibroid type and location, position relative to adjacent anatomical structures and the presence of co-existent pelvic disease. Additionally, successful outcomes with MRgFUS have been correlated with the volume of fibroids ablated during the procedure. Thus, selection of patients in whom sufficient fibroid volumes can be treated safely using the MRgFUS system is critical for successful outcomes. The MR images in this pictorial essay provide examples of uterine fibroids for which MRgFUS should be considered and is designed to facilitate the selection of patients for whom MRgFUS is most likely to provide sustained symptom relief."
"OBJECTIVE: To
estimate the cost-effectiveness of a treatment strategy for symptomatic
uterine fibroids, which starts with Magnetic Resonance-guided Focused
Ultrasound Surgery (MRgFUS) as compared with current practice comprising
uterine artery embolisation, myomectomy and hysterectomy." Non-invasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fibroids - early experience. Morita Y, Ito N, Hikida H, Takeuchi S, Nakamura K, Ohashi H. PubMed"CONCLUSION:
MRgFUS can safely be used to non-invasively treat symptomatic uterine
fibroids and avoid the need for surgical intervention in the short term.
With large treatment volumes, MRgFUS also results in significant fibroid
shrinkage in a relatively short time. Additional follow-up is needed to
determine the long-term durability of this promising non-invasive
approach." |
|
|||||||||||||
